Bio Medica Laboratories IPO GMP today is Rs -27.8. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
SME IPO
BIOMEDICA
Bio Medica Laboratories IPO GMP, Subscription & Allotment Status Today
Bio Medica Laboratories is a SME IPO with a price band of Rs 132.00 to Rs 139.00 that listed on 29 May 2026 at a listing gain of -20.00%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹132.00 - ₹139.00
- Lot Size
- 1,000 Shares
- Bidding Closes
- 25 May 2026
- Listing Date
- 29 May 2026
Current GMP Status
₹-27.8
-20% vs upper band
Est. Listing Gain
-20.00%
Last Trend
26 May 2026
Listing Price
₹111.20
Retail Entry
₹2,78,000
IPO Details
Complete IPO information
| Current GMP | ₹-27.8 |
|---|---|
| Estimated Listing Gain | -20.00% |
| Price Band | ₹132.00 - ₹139.00 |
| Issue Price | Approx ₹139.00 Crores |
| Listing Price | ₹111.20 |
| Lot Size | 1,000 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | 1.82x |
| Listing Date | 29 May 2026 |
| Minimum Investment | ₹2,78,000 |
Head-to-head
Compare Bio Medica Laboratories IPO with similar IPOs
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Bio Medica Laboratories is priced at ₹139 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,78,000 to participate in this SME issue.
The latest recorded Grey Market Premium for Bio Medica Laboratories stands at ₹-27.8, implying an estimated listing gain of around -20.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Bio Medica Laboratories's IPO was subscribed 1.82x overall, with a category-wise breakdown of Retail 2.33x, QIB 15.94x.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
21 May 2026
✓
Bidding Closes
25 May 2026
✓
Allotment
26 May 2026
✓
Listing
29 May 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 26 May 2026 | ₹0.00 | - | 0.00% |
| 25 May 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,78,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,78,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹4,17,000 |
| S-HNI Maximum | 7 Lot | 7,000 | ₹9,73,000 |
| B-HNI Minimum | 8 Lot | 8,000 | ₹11,12,000 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Bio Medica Laboratories IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹132 to ₹139 Per Share |
| Issue Size | Approx ₹52.43 Crores, 37,72,000 Equity Shares |
| Fresh Issue | Approx ₹47.19 Crores, 33,95,000 Equity Shares |
| Offer for Sale | Approx ₹5.24 Crores, 3,77,000 Equity Shares |
| Issue Type | Book Build Issue |
| IPO Listing | NSE SME |
Analysis
IPO Reservation<
| Investor Category | Share Offered | Shares (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 36,000 Shares | 50% |
| NII Shares Offered | 17,55,000 Shares | 15% |
| Retail Shares Offered | 17,92,000 Shares | 35% |
Analysis
Bio Medica Laboratories IPO Dates
The Bio Medica Laboratories IPO date is May 21 and the close date is May 25. The Bio Medica Laboratories IPO allotment will be finalized on May 26 and the IPO listing on May 28.
| Event | Date |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Basis of Allotment | May 26, 2026 |
| Refunds | May 27, 2026 |
| Credit to Demat Account | May 27, 2026 |
| IPO Listing Date | May 28, 2026 |
| IPO Bidding Cut-off Time | May 25, 2026 – 5 PM |
Analysis
Promoters and Holding Pattern
The promoters of the company are Mr. Mukesh Mehta and Mr. Pradeep Mehta.
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 91,80,001 | 99.99% |
| Promoter Holding Post Issue | 1,25,74,801 | -% |
Analysis
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
|---|---|
| Repayment of Loan | ₹7.25 |
| Enhancement of its Existing Production Capabilities by Setting Up of New Manufacturing Facility at the Existing Premises | ₹24.81 |
| General Corporate Purpose | ₹- |
Analysis
About Bio Medica Laboratories IPO
Bio Medica Laboratories is one of the leading manufacturers of parenteral medicines (injectable products) in India. The firm has been involved in developing a wide range of parenteral medicines targeting both human and animal needs. They manufacture generic medicines in the form of Liquid injections and dry powder injections, which come in various forms of packaging like ampoules and vials.
The company also claims to offer high-quality and safe products, followed by Good Manufacturing Practices (GMP and GLP). Moreover, the company has built a reputation for providing reliable yet effective solutions in the healthcare industry. Its product range includes injectables for the domestic market, Injectables for export, and Injectables for veterinary.
Analysis
Bio Medica Laboratories IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹16.25 | ₹15.80 | ₹0.33 | ₹17.57 |
| 2024 | ₹15.34 | ₹11.69 | ₹2.50 | ₹19.53 |
| 2025 | ₹38.33 | ₹25.18 | ₹9.79 | ₹39.12 |
| Nov 2025 | ₹28.63 | ₹16.95 | ₹8.66 | ₹65.17 |
Analysis
Bio Medica Laboratories IPO Valuation – FY2025
Check Bio Medica Laboratories IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
|---|---|
| ROE | 99.59% |
| ROCE | 48.20% |
| EBITDA Margin | 39.83% |
| PAT Margin | 25.64% |
| Debt to Equity Ratio | 1.02 |
| Earning Per Share (EPS) | ₹10.67 (Basic) |
| Price/Earning P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 99.59% |
| Net Asset Value (NAV) | ₹16.05 |
Analysis
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Zenotech Laboratories Limited | 0.92 | – | 6.01% | 15.76 | 5.61 Cr. |
| Shukra Pharmaceuticals Limited | 0.22 | 47.57 | 15.90% | 1.43 | 9.58 Cr. |
Analysis
IPO Lead Managers aka Merchant Bankers
- Narnolia Financial Services Ltd.
FAQ
Bio Medica Laboratories IPO FAQs
Bio Medica Laboratories IPO price band is Rs 132.00 to Rs 139.00. Check the latest issue price, lot size and GMP together before applying.
Bio Medica Laboratories IPO open date is 21 May 2026, close date is 25 May 2026, and listing date is 29 May 2026.
Bio Medica Laboratories IPO lot size is 1,000 shares. The minimum retail investment is Rs 2,78,000.
Bio Medica Laboratories is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Bio Medica Laboratories IPO subscription status currently shows Retail 2.33x, QIB 15.94x, Overall 1.82x.
Bio Medica Laboratories IPO issue size is TBA and the expected allotment date is 26 May 2026.
Community discussion
Comments
Share a useful question or insight about Bio Medica Laboratories.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
SME
R.K.Fashion Accessories
Price Band₹77.00 - ₹82.00
Current GMP₹0
Lot Size1,600 Shares
SME
Dove Soft
Price Band₹104.00 - ₹111.00
Current GMP₹0
Lot Size1,200 Shares
SME
Paramount Syntex
Price Band₹119.00 - ₹127.00
Current GMP₹0
Lot Size1,000 Shares
SME
Omara Ventures India
Price Band₹296.00 - ₹311.00
Current GMP₹0
Lot Size400 Shares
Loading comments...